Evaluation of Hepatic and Renal Function Algorithms for Fosravuconazole

Evaluation of Hepatic and Renal Function Algorithms for Fosravuconazole in Real-world Clinical Practice

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1070250090

Enrollment

130

Registered

2025-10-31

Start date

2025-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Onychomycosis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: patients diagnosed with onychomycosis by direct microscopy, treated with fosravuconazole between 20 March 2023 and 31 July 2025, and who underwent two laboratory tests: baseline and follow-up, during treatment.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
AST, ALT,GGT, SCr, and eGFR	—

Secondary

Measure	Time frame
Fold-change values of AST, ALT, GGt, SCr, and eGFR	—

Contacts

Public ContactShimoyama Harunari

Mizonokuchi dermatology and Medical Mycology Clinic

harunarishimoyama@med.teikyo-u.ac.jp+81-44-982-3111

Outcome results